A Vienna-based medical imaging AI company developing clinical decision support software to enhance the detection and management of lung diseases, including lung cancer, interstitial lung disease and COPD. The company develops proprietary AI solutions for the analysis of chest CT scans, including its CE-marked ADVANCE Chest CT product.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| not disclosed | Jun, 2026 | acquisition |
Frequently Asked Questions
Where is Contextflow located?
Contextflow is located in Vienna, Austria.
What industries does Contextflow operate in?
Contextflow operates in the following industries: medical imaging, artificial intelligence, clinical decision support, healthcare.
When was Contextflow founded?
Contextflow was founded on 2016-07-01.
Who are the investors in Contextflow?
The investors in Contextflow are: 4DMedical Limited.
What is the primary focus of Contextflow?
Contextflow specializes in developing AI-based software solutions for medical imaging, specifically designed to assist radiologists in detecting and characterizing lung diseases.
How does Contextflow support radiologists in their daily workflow?
Contextflow provides decision support tools that analyze medical images to quickly identify anomalies, provide relevant clinical information, and reduce the time spent on routine diagnostic tasks.
Is the technology developed by Contextflow clinically validated?
Yes, Contextflow products are CE-marked and undergo rigorous clinical evaluation to ensure they meet the safety and performance standards required for medical devices in clinical environments.